2.0%), the improvement in EFS did not reach statistical significance (HR 0.81), suggesting that not all immunotherapy combinations yield equivalent benefits ( 8 ).
← all excerpts
Perioperative immunotherapy in gastric cancer: walking a fine line between hope and caution.
1
—
—